PHC Group is a global healthcare company founded in 1969, headquartered in Tokyo, Japan. Its operations span diagnostics, life sciences, diabetes management, and healthcare IT, with a presence in over 90 countries. The company's portfolio of subsidiary brands includes Ascensia Diabetes Care, LSI Medience, WEMEX, Mediford, Epredia, and PHC Corporation.
Technical work within the group covers a wide range of domains. These include clinical testing services, cancer diagnostics, genetic testing, anatomical pathology, electronic medical record systems, and contract research for drug development. The life sciences division develops and manufactures laboratory equipment such as ultra-low temperature freezers, CO2 incubators, and solutions for cell therapy.
The group's scale is reflected in over 50 years of experience in the healthcare sector. Its client and operational base includes biopharmaceutical companies, biotechnology firms, academic research institutions, and government bodies. The company engages in strategic partnerships, including a collaboration with CCRM on T-cell expansion research.
